Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 192

SutroVax diagnoses $85m series C

Pivotal BioVenture Partners and Roche have both returned to back a series C round for SutroVax, which has also added TPG, Medicxi and Foresite Capital to its shareholders.

Jun 8, 2018

M17 ditches IPO at the last minute

M17 Entertainment, backed by MCN, Yahoo Japan and LeSports, was expected to float on the New York Stock Exchange yesterday but still has not begun trading.

Jun 8, 2018

Ant Financial pushes series C to $14bn

The round was already the largest ever at the previously reported $10bn mark but has been revealed to stand even taller with an additional $4bn.

Jun 8, 2018

EPropulsion stares into Beyond for $10m

Marine product maker EPropulsion, which was founded by a HKUST graduate, will soon launch a 4K resolution subsea drone camera.

Jun 8, 2018

AMC Entertainment lets Abry onto Screenvision

Abry has acquired cinema marketing distributor Screenvision for $380m in a deal which bagged AMC Entertainment a $45m return.

Jun 7, 2018

Camp4 discovers Kraft in its $30m A round

Camp4 has attracted capital from investors such as Kraft Group to continue development of its drug discovery platform based on work at MIT and Harvard Medical School.

Jun 7, 2018

Susquehanna unloads GlobalTranz

Freight brokerage GlobalTranz will be acquired by private equity firm Jordan Company after raising $50m from two rounds in 2014 and 2011.

Jun 7, 2018

Verity reaches series A heights

Airbus Ventures and Sony Innovation Fund have taken part in an $18m series A round for Verity Studios, which produces indoor drone technology.

Jun 7, 2018

Investors remain loyal to Stocard

Stocard, the developer of a mobile loyalty app backed by Cewe, has secured $20m from investors including Engelhorn.

Jun 7, 2018

HJB imparts series B+ knowledge

Taikang Life and Lilly Asia Ventures, which backed the initial $59.7m series B round last year, have also contributed to a $35m series B+ round of Hangzhou Just Biotherapeutics.

Jun 7, 2018
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here